Quantcast

Latest cyclophosphamide Stories

2014-05-29 10:42:58

University of Texas M. D. Anderson Cancer Center Oncologists now have a new understanding of the toxicity levels of specific chemotherapy regimens used for women with early stage breast cancer, according to research from The University of Texas MD Anderson Cancer Center. The retrospective study, published in the Journal of Clinical Oncology, used large population-based data to compare the risk of hospitalization for six common chemotherapy regimens. Reasons for hospitalization included...

Non-Toxic Therapy For Lupus Successfully Tested On Patients
2013-11-12 09:38:48

Rebekah Eliason for redOrbit.com – Your Universe Online Scientists from Northwestern Medicine have brought new hope to patients with lupus. A new nontoxic therapy that suppresses lupus in blood samples was designed and successfully tested on patients with the autoimmune disease. There is hope this treatment will replace the use of toxic drugs that carry nasty side effects with a vaccine like therapy. This new treatment could keep lupus in remission in the body. Lupus is a...

2013-08-01 14:43:22

In an article published today in the New England Journal of Medicine, Immune Tolerance Network (ITN) researchers demonstrated that a single course of rituximab therapy (anti-CD20; Rituxan, Genentech, Inc.) is as effective as the current standard of care regimen of drugs for remission induction and maintenance in patients with ANCA-associated Vasculitis (AAV). AAV is an autoimmune disease marked by the presence of antibodies that attack neutrophils and cause inflammation of the blood vessels,...

Drug Substitions Due To Shortages Could Prove Harmful For Cancer Patients
2012-12-27 13:20:56

Lee Rannals for redOrbit.com — Your Universe Online According to research led by St. Jude Children's Research Hospital, there is a connection between higher rates of relapse in pediatric cancer patients and drug shortages. A national drug shortage was linked to a higher rate of relapse among children, teenagers and young adults with Hodgkin's lymphoma, according to the national study. Survival from the condition went from 88 to 75 percent in two years after the drug...

2012-05-15 12:44:25

Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily. The findings provide valuable insight as to why some cancers metastasize to bone, and could eventually result in new metastasis-prevention drugs, said Laurie McCauley, professor in the Department of Periodontics and Oral Medicine at the University of Michigan School of Dentistry and principal...

2010-12-09 08:00:00

BRIDGEWATER, N.J., Dec. 9, 2010 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the final survival analysis (10-year follow-up) of the BCIRG001 study that included a Taxotere® (docetaxel) Injection Concentrate chemotherapy treatment regimen in the adjuvant breast cancer setting, as well as data from iniparib (BSI-201) pre-clinical and clinical breast cancer studies will be featured during the 33rd Annual San Antonio Breast...

2010-11-18 06:30:00

CALGARY, Nov. 18 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Children's Oncology Group (COG) intends to conduct a Phase I trial of REOLYSIN((R)) in combination with cyclophosphamide in pediatric patients with relapsed or refractory solid tumors. The study will be conducted in collaboration with the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.